06.09.2022 15:30:00

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT

NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

logo (PRNewsfoto/Halper Sadeh LLP)

Fortress Transportation and Infrastructure Investors LLC (NASDAQ: FTAI)'s merger with a subsidiary of FTAI Finance Holdco Ltd. If you are a Fortress shareholder, click here to learn more about your rights and options.

Silverback Therapeutics, Inc. (NASDAQ: SBTX)'s merger with ARS Pharmaceutic als, Inc. Under the terms of the merger agreement, assuming that Silverback's net cash at closing is $240 million, Silverback equity holders are expected to own approximately 37% of the combined company. If you are a Silverback shareholder, click here to learn more about your rights and options.

Covetrus, Inc. (NASDAQ: CVET)'s sale to funds affiliated with Clayton, Dubilier & Rice and TPG Capital for $21.00 per share in cash. If you are a Covetrus shareholder, click here to learn more about your rights and options.

Global Blood Therapeutics, Inc. (NASDAQ: GBT)'s sale to Pfizer Inc. for $68.50 per share in cash. If you are a Global Blood shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-notice-halper-sadeh-llp-investigates-ftai-sbtx-cvet-gbt-301618284.html

SOURCE Halper Sadeh LLP

Nachrichten zu Silverback Therapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Silverback Therapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Silverback Therapeutics Inc Registered Shs 14,51 -0,14% Silverback Therapeutics Inc Registered Shs